摘要:
An automatic frequency correction (AFC) apparatus used for CDMA multipath fading channels comprises a frequency-offset evaluator, an automatic frequency correction loop filter and a carrier frequency adjuster. The present invention provides a “multipath energy window” designing method for the non-determinacy of multipath signals in mobile communication environment. Frequency-offset information can be extracted from the multipath energy window by a simple calculation and evaluated by a maximal SNR weight process. This invention also provides a step-variable accumulation adjusting method and greatly improves the response speed of the AFC apparatus as compared with a conventional loop filter, whereby supplies better AFC required for CDMA mobile terminals.
摘要:
In one embodiment, a brightness enhancement film comprises: a diffusing film comprising a front surface and a back surface, a coating on the front surface, and light redirecting structures disposed in the coating. The brightness enhancement film is capable of collimating light, and wherein, without the coating, the diffusing film would be capable of spread light passing through the back surface. In another embodiment, the brightness enhancement film comprises: a diffusing film comprising a front surface and a back surface, a coating on the front surface, and light redirecting structures disposed in the coating. The diffusing film has a stress retardation gradient of less than or equal to 50 nm/in, wherein an interval for calculation of the stress retardation gradient is less than 1 inch. The brightness enhancement film is capable of collimating light.
摘要:
A stream of images including an area occupied by at least one object are processed to extract wavelet coefficients, and the extracted coefficients are represented as wavelet signatures that are less susceptible to misclassification due to noise and extraneous object features. Representing the wavelet coefficients as wavelet signatures involves sorting the coefficients by magnitude, setting a coefficient threshold based on the distribution of coefficient magnitudes, truncating coefficients whose magnitude is less than the threshold, and quantizing the remaining coefficients.
摘要:
A method of inspecting a light-management film comprises reflecting light from an overhead light source off a first side of the light-management film and examining the light-management film for defects; directing transmission light from a backlight source through a second side of the light-management film to the first side and examining the light-management film for defects; reflecting light from the overhead light source off the second side of the light-management film and examining the light-management film for defects; directing transmission light from the backlight source through the first side of the light-management film to the second side and examining the light-management film for defects; and measuring a location of each of the examined defects in the light-management film.
摘要:
A compound of Formula (I) wherein R1, R2, R3, R4, R5, and R6 are as defined herein, or a tautomer, prodrug, solvate, or salt thereof; pharmaceutical compositions containing such compounds, and methods of modulating the glucocorticoid receptor function and methods of treating disease-states or conditions mediated by the glucocorticoid receptor function or characterized by inflammatory, allergic, or proliferative processes in a patient using these compounds.
摘要:
A method and system for ensuring data integrity in a data processing system may comprise monitoring when data for a specified device is available for error correction code generation, and receiving a first indication of the specified device, a second indication of the data, and a third indication of a size of the data during the monitoring. A new error correction code may be generated in hardware for the data based on the indicated size of the data and an indication may be provided to signal when generation of the new error correction code for a specified number of accesses for at least a portion of the data is complete. Detected errors may be corrected in software based on the newly generated error correction code. The first indication may be a device selection signal and the error correction code generation may be enabled or disabled via an enable signal.
摘要:
Controlling the flow of network traffic to avoid undesired delay in the transmission of timing sensitive packets is disclosed. A plurality of packets to be transmitted via a network transmission path is monitored. A time at which a timing sensitive packet will become available for transmission via the network transmission path is anticipated. The plurality of packets is controlled in light of the anticipated time so that packets other than the timing sensitive packet will not occupy the network transmission path at a time associated with the anticipated time. Approximating a maximum data transmission rate associated with a network transmission path by sending and analyzing receipt of a series of test packets is disclosed. Approximating a buffer size of a buffer associated with a network transmission path by sending and analyzing receipt of a series of test packets is disclosed.
摘要:
The present invention relates to novel lipopeptide compounds. The invention also relates to pharmaceutical compositions of these compounds and methods of using these compounds as antibacterial compounds. The invention also relates to methods of producing these novel lipopeptide compounds and intermediates used in producing these compounds.
摘要:
The invention features 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs, compositions containing them, and methods of using them as PPAR modulators to treat or inhibit the progression of, for example, dyslipidemia.
摘要:
The present invention relates to substantially pure FXR1 and FXR2 proteins and isolated nucleic acid molecules encoding the same. Recombinant expression vectors comprising nucleic acid sequences that encode FXR1 and FXR2 protein are also provided. Antibodies which bind to an epitope of FXR1 or FXR2, or FMR1 protein are also provided. The present invention also relates to methods of screening individuals for FMR1 deficiency using antibodies or nucleic acid molecules of the invention and pharmaceutical kits for accomplishing the same.